"Baptist Health Lexington, a 434-bed tertiary care facility, is also a major medical research and education center. Established in 1954, Baptist Health Lexington is recognized for its excellence in heart care and cancer care, and the hospital's Clinical Research Center conducts groundbreaking research in both fields. Baptist Health Lexington continues to lead in maternity care, having delivered nearly 160,000 babies. The hospital operates outlying outpatient centers in Georgetown, Nicholasville and Richmond."

During the past decade, Baptist Health Lexington conducted 143 clinical trials. In the 10-year time frame, 143 clinical trials started and 117 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 63 clinical trials were completed. i.e. 110.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Health Lexington" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "Abbott Medical Devices" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored and "SWOG Cancer Research Network" with 25 trials sponsored. Other sponsors include 158 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health Lexington" #1 collaborator was "National Cancer Institute (NCI)" with 108 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health Lexington" are "Breast Cancer" (24 trials), "Heart Failure" (23 trials), "Lung Cancer" (14 trials), "Colorectal Cancer" (13 trials) and "Coronary Artery Disease" (12 trials). Many other conditions were trialed in "Baptist Health Lexington" in a lesser frequency.

Most popular intervention types in "Baptist Health Lexington" are "Drug" (178 trials), "Other" (95 trials), "Device" (85 trials), "Procedure" (58 trials) and "Biological" (56 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (31 trials), "radiation therapy" (27 trials), "Paclitaxel" (25 trials) and "Carboplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health Lexington" are 248 trials for "All" genders, 56 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Baptist Health Lexington". undefined are not yet recruiting, 45 are recruiting, 69 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 149 completed trials in Baptist Health Lexington, 2 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health Lexington, 12 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 58 trials that are defined as “Not Applicable".

Baptist Health Lexington has several departments that took part in Clinical trials: "Baptist Health Lexington Oncology Associates" - 3 trials, "Lexington Oncology Associates" - 2 trials